The Chinese government's Volume-Based Procurement (VBP) policy has been the single most disruptive force in the China Orthopedic Devices Market. Designed to lower the price of medical consumables by leveraging the vast purchasing power of the public healthcare system, VBP has led to dramatic price cuts, with some implants seeing reductions of over 80%. This has fundamentally reshaped the...